Your search returned 88 studies. (Get alerts for new studies):
- Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - AML
1 Location available
- Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Conditions: Leukemia, Myeloid - Leukemia - Acute Myeloid Leukemia (AML)
5 Locations available
- Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS - AML - Solid Tumors - Multiple Myeloma - Non-Hodgkin's Lymphoma - Hodgkin's Disease
8 Locations available
- Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Conditions: Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - Juvenile Myelomonocytic Leukemia - Myelodysplastic Syndrome - Non-Hodgkin's Lymphoma
1 Location available
- A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives
Conditions: Obesity - Hypertension
1 Location available
- Pramlintide in Adolescents With Type 1 Diabetes
Conditions: Type 1 Diabetes
1 Location available
- Randomized Allogeneic Azacitidine Study
Conditions: Leukemia - AML - MDS
1 Location available
- Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
Conditions: Leukemia, Myeloid, Acute - Myelodysplastic Syndromes
1 Location available
- Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
Conditions: Acute Myeloid Leukemia (AML)
23 Locations available
- Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Conditions: Pediatric Acute Myelogenous Leukemia (AML)
15 Locations available
- Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using
Conditions: Acute Myeloid Leukemia
1 Location available
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML)
7 Locations available
- Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in P
Conditions: Acute Myelogenous Leukemia (AML)
5 Locations available
- Trial of a WT-1 Analog Peptide Vaccine in Patients With Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia
1 Location available
- A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
1 Location available
- A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
Conditions: AML
1 Location available
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant
Conditions: AML - ALL - Undifferentiated Leukemia - Biphenotypic Leukemia - Refractory Anemia - Refractory Anemia With Ringed Sideroblasts - Refractory Cytopenia With Multilineage Dysplasia - Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts -
2 Locations available
- Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Conditions: Male and Female Subjects, Greater Than 60 Years of Age With Non-M3 AML
1 Location available
- Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Non-Hodgkin's Lymphoma
2 Locations available
- A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Conditions: AML - ALL - CML in Blast Crisis - High-Risk MDS - Multiple Myeloma
5 Locations available
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Conditions: Type 1 Diabetes
1 Location available
- POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients
Conditions: Relapsed/Refractory AML - Relapsed/Refractory ALL - Secondary AML/MDS - Acute Leukemia of Ambiguous Lineage - AML - ALL
1 Location available
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
8 Locations available
- Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Conditions: Gram-negative Bacterial Infections
1 Location available
- Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
Conditions: Acute Myeloid Leukemia
1 Location available
- A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
2 Locations available
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Conditions: Leukemia, Myelogenous, Acute - Myelodysplastic Syndromes
1 Location available
- Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Conditions: AML
2 Locations available
- A Study of Two Subcutaneous Regimens of SGI-110, a DNA Hypomethylating Agent, in Subjects With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Le
Conditions: MDS - CMML - AML
7 Locations available
- A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute
5 Locations available
- Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Conditions: Leukemia - Acute Myeloid Leukemia (AML) - Myelodysplastic Syndromes (MDS)
1 Location available
- TL32711 in Elderly Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Synd
Conditions: Leukemia
1 Location available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
Conditions: Acute Myeloid Leukemia
2 Locations available
- Safety and Tolerability of AZD1208 and the Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Conditions: Acute Myeloid Leukemia
2 Locations available
- Stem Cell Transplantation for Hematological Malignancies
Conditions: Leukemia, Lymphocytic, Acute - AML - MDS
1 Location available
- Stem Cell Transplant for Hematological Malignancy
Conditions: Leukemia, Myeloid, Chronic - AML - Leukemia, Lymphocytic, Acute - MDS - Leukemia, Lymphocytic, Chronic - JMML - Hodgkin's Disease - Non-hodgkin's Lymphoma - Multiple Myeloma
1 Location available
- Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
Conditions: Leukemia - Myelodysplastic Syndrome
1 Location available
- Allogeneic Stem Cell Transplant With Clofarabine, Ara-C and TBI for AML and ALL
Conditions: Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia
1 Location available
- Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML) - Myelodysplastic Syndrome (MDS)
1 Location available
- Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
Conditions: Type 2 Diabetes
1 Location available
- Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Conditions: Acute Myeloid Leukemia - Myelodysplastic Syndromes - Lymphoma - Multiple Myeloma - Leukemia, Myelomonocytic, Chronic
4 Locations available
- Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
Conditions: Acute Myelogenous Leukemia - AML
1 Location available
- Clinical Trial of L-Grb-2 Antisense Oligonucleotide in CML, AML, ALL & MDS
Conditions: Safety and Pharmacokinetics of L-Grb-2 in Treating CML, AML, CLL and MDS
1 Location available
- Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Safety and Efficacy of 72-hour and 120-hour Infusion of ON 01910.Na in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)
Conditions: Acute Myeloid Leukemia - Acute Myelocytic Leukemia - Acute Lymphoid Leukemia - Acute Lymphocytic Leukemia
1 Location available
- Selecting a Favorable KIR Donor in Unrelated HCT for AML
Conditions: Acute Myelogenous Leukemia
12 Locations available
- Seamless Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable
Conditions: Lung Cancer
1 Location available
- Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
1 Location available
- Alvocidib (Flavopiridol), Ara-C and Mitoxantrone (FLAM) Versus "7+3" for Newly (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Conditions: Acute Myeloid Leukemia (AML) - Acute Promyelocytic Leukemia (APL) - Refractory Anemia With Excess of Blasts (RAEB)
2 Locations available
- A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute,
1 Location available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
Conditions: Non-Hodgkin's Lymphoma (NHL) - Hodgkin's Disease - Chronic Lymphocytic Leukemia (CLL) - Acute Myelogenous Leukemia (AML) - Acute Lymphoblastic Leukemia (ALL) - MDS
3 Locations available
- A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Conditions: Hematologic Malignancy - Leukemia - Acute Lymphoblastic Leukemia - ALL - Acute Myelogenous Leukemia - AML - Chronic Lymphocytic Leukemia - CLL - Lymphoma - Hodgkin's Lymphoma - Non-hodgkin's Lymphoma - Myeloma
1 Location available
- Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute
1 Location available
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
38 Locations available
- Study of KB004 in Subjects With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia (AML) - Acute Lymphocytic Leukemia (ALL) - Chronic Myelogenous Leukemia (CML) - Myelodysplastic Syndrome (MDS) - Myeloproliferative Neoplasms (MPN)
2 Locations available
- Closed Loop System With Pramlintide Versus Exenatide
Conditions: Type 1 Diabetes
1 Location available
- Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Leukemia
1 Location available
- Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk
Conditions: Leukemia
1 Location available
- Monitoring Minimal Residual Disease Following Treatment of Patients With Acute Myeloid Leukemia (AML) or High Grade Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia - High Grade Myelodysplastic Syndrome
3 Locations available
- Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
Conditions: Acute Myelogenous Leukemia
7 Locations available
- Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
1 Location available
- T-Cell Depleted Double UCB for Refractory AML
Conditions: Acute Myelogenous Leukemia - Refractory Acute Myelogenous Leukemia
1 Location available
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Synd
Conditions: Disorder Related to Bone Marrow Transplantation - Leukemia - Transplantation Infection
1 Location available
- Post Transplant Donor Lymphocyte Infusion
Conditions: Leukemia, Myeloid, Chronic - Lymphomas - Multiple Myeloma - Myelodysplastic Syndrome - Leukemia, Lymphocytic, Acute - Leukemia, Lymphocytic, Chronic - AML
1 Location available
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL) - Leukemia, Myeloid, Acute(AML) - Leukemia, Myeloid, Chronic(CML) - Juvenile Myelomonocytic Leukemia (JMML) - Hemoglobinuria, Paroxysmal Nocturnal (PNH) - Hodgkin Lymphoma - Lymphoma, Non-Hodgkin (NHL) - Myelodysplastic S
1 Location available
- Trial of High Dose Lenalidomide in Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Trilineage Dysplasia (AML-TLD)
Conditions: Myelodysplastic Syndrome
1 Location available
- Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Conditions: Acute Myeloid Leukemia - Infantile Leukemia (Both AML and ALL) - Myelodysplastic Syndrome - Myelodysplastic/Myeloproliferative Neoplasms - Biphenotypic Leukemia
1 Location available
- Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
Conditions: Acute Myelogenous Leukemia - Leukemia
1 Location available
- Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
3 Locations available
- Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia - Myelodysplastic Syndrome
1 Location available
- Pramlintide Combined With Model Predictive Control Algorithm
Conditions: Type 1 Diabetes Mellitus
1 Location available
- Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen
Conditions: Acute Myeloblastic Leukemia
1 Location available
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndrome - Leukemia
1 Location available
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Conditions: Leukemia
1 Location available
- Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients
Conditions: Acute Myeloid Leukemia - AML
1 Location available
- Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL) - Acute Myelogenous Leukemia (AML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma - Hodgkin's Disease
2 Locations available
- Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649 AM2)
Conditions: Acute Myelogenous Leukemia (AML)
3 Locations available
- Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia
1 Location available
- Perindopril Amlodipine for the Treatment of Hypertension
Conditions: Essential Hypertension
48 Locations available
|